1Inoue T,Node K.Statin therapy for vascular failure[J].Cardiovasc Drugs Ther,2007,21(4):281-295.
2Zhou Q,Liao JK.Statins and cardiovascular diseases:from cholesterol lowering to pleiotropy[J].Curr Pharm Des,2009,15(5):467-478.
3Jrvisalo MJ,Toikka JO,Vasankari T,et al.HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease[J].Atherosclerosis,1999,147(2):237-242.
4Kureishi Y,Luo Z,Shiojima I,et al.The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals[J].Nat Med,2000,6(9):1004-1010.
5Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial[J].JAMA,2004,291(9):1071-1080.
6Chan KC,Wang CJ,Ho HH,et al.Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53[J].Pharmacol Res,2008,58 (3-4):247-256.
7Rupérez M,Rodrigues-Díez R,Blanco-Colio LM,et al.HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis:role of RhoA/ROCK and MAPK pathways[J].Hypertension,2007,50(2):377-383.
8Ridker PM,Danielson E,Fonseca FA,et al.Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein[J].N Engl J Med,2008,359(21):2195-2207.
9Tavridou A,Efthimiadis A,Efthimiadis I,et al.Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease[J].Eur J Clin Pharmacol,2006,62(6):485-489.
10Rikitake Y,Kawashima S,Takeshita S,et al.Anti-oxidative properties of fluvastatin,an HMG-CoA reductase inhibitor,contribute to prevention of atherosclerosis in cholesterol-fed rabbits[J].Atherosclerosis,2001,154(1):87-96.
7MARON DJ, FAZIO S, LINTON MF. Current perspec- tives on statins [J].Circulation, 2000,101 (2) : 207-213.
8SHIMIZU K, AIKAWA M, TAKAYAMA K, et al. Di- rect antiinflammatory mechanisms contribute to attenua- tion of experimental allograft arteriosclerosis by statins [J].Circulation, 2003,108(17) : 2113-2120.
9WILLIAMS JK, SUKHOVA GK, HERRINGTON DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J]. J Am Coil Cardiol, 1998,31 (3) :684-691.
10YOSHIDA M,SAWADA T, ISHII H,et al. HMG-CoA inhibitor modulates monocyte-endothelial cell interaction under physiological flow condition in vitro: involvement of Rho GTPase-dependent mechanism [J]. Arterioscler Thromb Vase Biol,2001,21(7) :1165-1171.